Survival Benefit of Implantable-Cardioverter Defibrillator Therapy in Ambulatory Patients With Left Ventricular Assist Device

Simsek, EVRİM; Nalbantgil, S; Demir, E; Kemal, HS; Mutlu, I; Ozturk, PELİN; Engin, ÇAĞATAY; Yagdi, TAHİR; Ozbaran, M

doi:10.1016/j.transproceed.2019.06.010

Survival Benefit of Implantable-Cardioverter Defibrillator Therapy in Ambulatory Patients With Left Ventricular Assist Device

Atıf İçin Kopyala

Simsek E. , Nalbantgil S., Demir E., Kemal H., Mutlu I., Ozturk P. , ...Daha Fazla

TRANSPLANTATION PROCEEDINGS, cilt.51, ss.3403-3408, 2019 (SCI İndekslerine Giren Dergi)

Cilt numarası: 51 Konu: 10
Basım Tarihi: 2019
Doi Numarası: 10.1016/j.transproceed.2019.06.010
Dergi Adı: TRANSPLANTATION PROCEEDINGS
Sayfa Sayıları: ss.3403-3408

Özet

Background. Analysis of the prognostic effect of concomitant use of left ventricular assist devices (LVADs) and implantable -cardioverter defibrillators (ICDs) is lacking. The aim of this study is to define the survival effects of ICD therapy in ambulatory patients with LVAD.